XML 31 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2019
Revenue Recognition  
Schedule of disaggregation of revenue by test families

Year Ended December 31,

2019

2018

2017

(Amounts in thousands)

Product revenues

Sale of genetic tests

$

269,881

$

240,366

$

203,777

Licensing and other

 

Upfront license and Constellation and paternity

5,089

10,344

4,229

License and development services

16,379

294

Other

10,979

6,650

1,619

Licensing and other revenues

32,447

17,288

5,848

Total revenues

$

302,328

$

257,654

$

209,625

Schedule of disaggregation of revenue by payer types

Year Ended December 31,

2019

2018

2017

(Amounts in thousands)

Insurance carriers

$

210,919

$

193,895

$

163,861

Laboratory partners

59,876

44,062

36,001

Patients

31,533

19,697

9,763

Total revenues

$

302,328

$

257,654

$

209,625

Schedule of total revenue by geographic area

Year ended December 31, 

2019

    

2018

    

2017

(Amounts in thousands)

United States

$

260,846

 

$

225,931

 

$

185,533

Americas, excluding U.S.

3,218

 

3,472

 

3,028

Europe, Middle East, India, Africa

15,434

 

20,866

 

13,998

Asia Pacific and Other

22,830

 

7,385

 

7,066

Total

$

302,328

 

$

257,654

$

209,625

Schedule of beginning and ending balances of accounts receivable and deferred revenues

Balance at

Balance at

December 31,

December 31,

2019

2018

(Amounts in thousands)

Assets:

Accounts receivable

$

53,351

$

62,223

Liabilities:

Deferred revenue, current portion

$

56,016

$

4,131

Deferred revenue, long-term portion

23,808

40,058

Total deferred revenues

$

79,824

$

44,189

Schedule of changes in the balance of deferred revenues

Deferred

Revenues

(in thousands)

Balance at December 31, 2018

$

44,189

Increase in deferred revenues

65,026

Revenue recognized during the period that was included in
deferred revenues at the beginning of the period

(970)

Revenue recognized from performance obligations satisfied
within the same period

(23,209)

Transferred in the sale of business

(5,212)

Balance at December 31, 2019

$

79,824

Schedule of insurance carrier reserve balance

    

December 31, 

    

December 31, 

    

2019

    

2018

(Amounts in thousands)

Beginning balance

$

10,012

$

6,795

Additional reserves

9,560

10,295

Reserves released

(10,162)

(7,078)

Ending balance

$

9,410

$

10,012

Released into revenue

$

2,410

$

3,324